DUSA Pharmaceuticals (DUSA) Reports Second Quarter 2012 Corporate Highlights and Financial Results  
8/2/2012 10:18:17 AM

WILMINGTON, Mass., Aug. 2, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), reported today its corporate highlights and financial results for the second quarter ended June 30, 2012.